ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q3SCImago #20,360Hybrid

Signa Vitae

Abbreviation (ISO):SIGNA VITAE
•
Identifier (ISSN):1334-5605(Print)/1845-206X(Online)
•
Publisher:Pharmamed Mado Ltd.
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend (2018–2025)

Clarivate IF trend for Signa Vitae

WoS Q1
01120.1320180.1720190.3420200.6320210.9120221.12023120240.62025
Annual Impact Factor Metric
Current (2025):0.6
Scopus SJR & RankScopus Q3
0.227
#20,360

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
17

17 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate10%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
169articles/year
4.99% Gold OA•81% Original Research

Aims & Scope

Signa Vitae is a completely open-access,peer-reviewed journal dedicate to deliver the leading edge research in anaesthesia, intensive care and emergency medicine to publics. The journal’s intention is to be practice-oriented, so we focus on the clinical practice and fundamental understanding of adult, pediatric and neonatal intensive care, as well as anesthesia and emergency medicine. Although Signa Vitae is primarily a clinical journal, we welcome submissions of basic science papers if the authors can demonstrate their clinical relevance. The Signa Vitae journal encourages scientists and academicians all around the world to share their original writings in the form of original research, review, mini-review, systematic review, short communication, case report, letter to the editor, commentary, rapid report, news and views, as well as meeting report. Full texts of all published articles, can be downloaded for free from our web site.

Topics Covered (Recognized by AI)
MedicineInternal medicine82.8%Biology72.4%Surgery70.9%Psychology61.1%Psychiatry55.7%Anesthesia53.2%Pathology42.4%Radiology37.9%Cardiology33.5%Intensive care medicine30.4%Chemistry28.6%Physics28.4%Genetics24.8%Endocrinology23.5%Emergency medicine23.2%Biochemistry21.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF—
Articles / Year73
Total Citations2
2025
IF0.6
Articles / Year201
Total Citations88
2024
IF1
Articles / Year151
Total Citations179
2023
IF1.1
Articles / Year128
Total Citations160
2022
IF0.907
Articles / Year82
Total Citations216

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #20,360Scopus Q3SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.227

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.83

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,464 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations350
3-Year Documents441
Citable Documents431

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Critical Care and Intensive Care MedicineQ3
Emergency MedicineQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 10%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区EMERGENCY MEDICINE
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Signa Vitae (abbr: SIGNA VITAE, ISSN: 1334-5605) is a peer-reviewed international scholarly journal in the field of Medicine, published by Pharmamed Mado Ltd. in Croatia since 2004. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.227 (Q3), an H-index of 17.

The journal enforces rigorous peer evaluation with a publication frequency of Semiannual, an annual output of approximately 169 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,464 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Pharmamed Mado Ltd.
Publication Language
English
Frequency
Semiannual
Founding Year
2004
Indexing & Databases
SCIEScopusPubMed
Editorial Address
PHARMAMED MADO LTD, ZATISJE 8 G, ZAGREB, CROATIA, 10000

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8bc95a5f-28ea-4a5a-8395-6519944cb65b
Database Updated: 2026-10-01